grant

Characterisation of a New Poor-Risk Sub-Category of Chronic Phase Chronic Myeloid Leukaemia [ 2012 - 2015 ]

Also known as: Elucidating the underlying biology of CP-CML patients who respond poorly to targeted therapy.

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1026932]

Researchers: Prof Deborah White (Principal investigator) ,  Prof Richard D'Andrea Prof Timothy Hughes

Brief description The introduction of targeted therapy for chronic myeloid leukaemia (CML) has resulted in excellent responses for many patients. However, some 30-40% of patients respond very poorly to this therapy and therapeutic advances are urgently needed to improve response in these patients. In order to better treat these poor risk patients we aim, in this project, to develop a greater understanding of their disease, and from this identify specific cellular targets for future drug treatment/combination therapy.

Funding Amount $AUD 609,320.27

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]